Cryopreserved leukapheresis enables scalable and distributed CAR-T manufacturing: a multi-platform comparative study
Abstract Cryopreserved leukapheresis is a scalable source for Chimeric antigen receptor T (CAR-T) manufacturing, yet it remains understudied (18.3% of 349 studies, 2010–2024). Current challenges include that cryopreserved leukapheresis lacks a standardized preparation process and has a low level of...
Saved in:
| Main Authors: | Menglin Ren, Xiaodie Wang, Jiangrui Chen, Yuanjian Xu, Yan Sun, Tao Liu, Qijun Qian, Zenghui Xu |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Nature Portfolio
2025-08-01
|
| Series: | Scientific Reports |
| Subjects: | |
| Online Access: | https://doi.org/10.1038/s41598-025-14865-5 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
European survey on CAR T-Cell analytical methods from apheresis to post-infusion immunomonitoring
by: Biagio De Angelis, et al.
Published: (2025-04-01) -
Promising approach for targeting ROBO1 with CAR NK cells to combat ovarian cancer primary tumor cells and organoids
by: Yan Zhu, et al.
Published: (2024-12-01) -
Flow‐based immunomagnetic enrichment of circulating tumor cells from diagnostic leukapheresis product
by: Michiel Stevens, et al.
Published: (2025-07-01) -
Case Report: A case of infantile acute hyperleukocytic leukemia treated by leukapheresis
by: Shuang Bian, et al.
Published: (2024-12-01) -
Regulation of CAR transgene expression to design semiautonomous CAR-T
by: Paweł Głowacki, et al.
Published: (2024-09-01)